Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gang Yang1, Xiaoshen Wang1

  • 1Department of Radiation Oncology Eye & ENT Hospital Fudan University Shanghai China.

Precision Radiation Oncology
|May 8, 2025
PubMed
Summary
This summary is machine-generated.

Sinonasal teratocarcinosarcoma (SNTCS), a rare and aggressive cancer, typically affects the ethmoid or maxillary sinus. This case highlights successful treatment of advanced SNTCS using surgery, chemoradiotherapy, and targeted therapy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study.

Journal of applied clinical medical physics·2026
Same author

Integrating static angle ports and dynamic collimator rotation in volumetric modulated arc therapy for hypofractionated whole breast irradiation in Chinese females: a single-centre dosimetric study.

Radiation oncology (London, England)·2026
Same author

Survival Outcomes and Late Toxicity of Postoperative Radiotherapy in Patients With Adenoid Cystic Carcinoma of the External Auditory Canal.

Cancer medicine·2025
Same author

A human-STING specific macrocyclic peptide suppresses cGAS-STING-induced inflammation.

Annals of the rheumatic diseases·2025
Same author

Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.

Cancer treatment reviews·2025
Same author

Molecular mechanism of the type 2 defense-associated reverse transcriptase.

Nucleic acids research·2025
Same journal

A new perspective on radiotherapy in the comprehensive treatment of cancer.

Precision radiation oncology·2026
Same journal

One-year follow-up after fractionated ultra-high-dose-rate FLASH radiotherapy in patient with extramammary Paget disease of the scrotum.

Precision radiation oncology·2026
Same journal

A new perspective on cancer treatment: the interaction and application prospect between ICIs and radiotherapy.

Precision radiation oncology·2026
Same journal

Advances in mucosal injury mechanisms in radiation-induced esophagitis associated with thoracic radiotherapy.

Precision radiation oncology·2026
Same journal

Dosimetric comparison of lattice radiotherapy across three modern linear accelerator platforms.

Precision radiation oncology·2026
Same journal

Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3-4a esophageal squamous cell carcinoma: A matched cohort analysis.

Precision radiation oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Pathology

Context:

  • Sinonasal teratocarcinosarcoma (SNTCS) is an exceptionally rare malignancy.
  • SNTCS predominantly affects the ethmoidal or maxillary sinuses.
  • The condition exhibits a highly aggressive nature with a poor prognosis, evidenced by a 2-year survival rate of 55%.

Purpose:

  • To present a successful treatment case of advanced SNTCS.
  • To review existing literature on SNTCS.

Summary:

  • A case of advanced SNTCS was successfully treated with a multimodal approach.
  • The treatment regimen included surgery, followed by chemoradiotherapy and targeted therapy.
  • Literature on this rare sinonasal malignancy was also reviewed.

Impact:

  • Demonstrates a potentially effective treatment strategy for advanced SNTCS.
  • Contributes to the limited body of knowledge on SNTCS management.
  • Offers insights into managing rare sinonasal cancers.